The incorporation of OPN into a CI-AKI risk model markedly enhanced predictive accuracy, elevating the c-statistic from 0.69 to 0.73 (p < 0.001) and improving risk stratification for subsequent cardiorenal outcomes and CKD progression [137]. The gene discussed is SPP1; the disease is chronic kidney disease.